Edition:
United Kingdom

Taro Pharmaceutical Industries Ltd (TARO.N)

TARO.N on New York Stock Exchange

105.30USD
17 Jan 2018
Change (% chg)

$0.41 (+0.39%)
Prev Close
$104.89
Open
$105.49
Day's High
$105.86
Day's Low
$104.82
Volume
13,548
Avg. Vol
34,722
52-wk High
$128.25
52-wk Low
$95.62

Chart for

About

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical... (more)

Overall

Beta: 0.66
Market Cap(Mil.): $4,626.61
Shares Outstanding(Mil.): 40.51
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.11 16.44
EPS (TTM): -- -- --
ROI: -- 14.85 10.61
ROE: -- 16.31 14.21

BRIEF-Bellus Health Receives Milestone Payment From Taro Pharmaceuticals

* BELLUS HEALTH RECEIVES MILESTONE PAYMENT FROM TARO PHARMACEUTICALS Source text for Eikon: Further company coverage:

09 Jan 2018

BRIEF-Taro Pharmaceutical quarterly earnings per share $1.30

* Taro Pharmaceutical Industries Ltd-qtrly ‍shr $1.30​ Source text for Eikon: Further company coverage:

08 Nov 2017

BRIEF-Taro announces joining of CEO

* Taro Pharmaceutical Industries Ltd - ‍ Uday Baldota has joined company as its chief executive officer ("CEO") effective August 28, 2017​

01 Sep 2017

Indian shrs fall for 3rd day; US-N.Korea tensions spook investors

Aug 9 Indian shares fell for a third consecutive session on Wednesday, dragged down by financial and healthcare stocks, as escalating tensions on the Korean peninsula hit regional markets.

09 Aug 2017

BRIEF-Taro reports quarterly net income per ordinary share $1.35

* Qtrly net income per ordinary share $1.35 Source text for Eikon: Further company coverage:

09 Aug 2017

Earnings vs. Estimates